✦ LIBER ✦

Combining drug–disease and economic modelling to inform drug development decisions

✍ Scribed by Bill Poland; Russell Wada

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health economics in drug development: Ef

✍ Peter S. Hall; Christopher McCabe; Julia M. Brown; David A. Cameron 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 457 KB

The Evaluation and Use of Economic Evide

✍ Yong, Jean H. E.; Beca, Jaclyn; Hoch, Jeffrey S. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 258 KB

Bayesian Quantitative Disease–Drug–Trial

✍ Joo Yeon Lee; Jogarao V. S. Gobburu 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 737 KB

Pharmacometrics: modelling and simulatio

✍ R. Gieschke; J-L. Steimer 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 975 KB

Animal models of Alzheimer's disease and

✍ Laurijssens, Bart; Aujard, Fabienne; Rahman, Anisur 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Applying computational modeling to drug

✍ Neil Kumar; Bart S. Hendriks; Kevin A. Janes; David de Graaf; Douglas A. Lauffen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 246 KB